Intensity Therapeutics prices $4M registered direct offering of 5M shares at $0.80

INTENSITY THERAPEUTICS, INC.

Gross proceeds of $4.0M from sale of 5M shares at $0.80 per share; closing expected Nov 3, 2025.
Net proceeds to fund clinical trial advancement, working capital, and general corporate purposes.
Cash runway expected to extend to end of Q1 2027 after the offering closes.
A.G.P./Alliance Global Partners is sole placement agent; fee 7% of gross proceeds plus up to $50k expenses.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.